scispace - formally typeset
R

R. Paul Maguire

Researcher at Pfizer

Publications -  11
Citations -  10826

R. Paul Maguire is an academic researcher from Pfizer. The author has contributed to research in topics: Cerebral blood flow & Medicine. The author has an hindex of 9, co-authored 9 publications receiving 8468 citations. Previous affiliations of R. Paul Maguire include University Medical Center Groningen.

Papers
More filters
Journal ArticleDOI

Effect of fenfluramine-induced increases in serotonin release on [18F]MPPF binding: A continuous infusion PET study in conscious monkeys

TL;DR: Results showed a 20‐ and 35‐fold increase in extracellular 5‐HT levels in the prefrontal cortex after injection of FEN at a dose of 5 mg/kg and 10mg/kg respectively, but no differences in BP were found between the control and FEN scans, which may imply that the majority of 5‐ HT1A receptors is in the low affinity state in the living brain.
Journal ArticleDOI

Evaluation of [(11)C]MRB for assessment of occupancy of norepinephrine transporters: Studies with atomoxetine in non-human primates.

TL;DR: This study demonstrated that [(11)C]MRB is suitable for drug occupancy studies of NET, and caudate was found to be the most suitable for preclinical drug occupancy Studies in rhesus monkeys.
Journal ArticleDOI

Methylphenidate-induced activation of the anterior cingulate but not the striatum: a [15O]H2O PET study in healthy volunteers.

TL;DR: It is suggested that the combined MP challenge with functional imaging, as described in this study, may be a useful tool to study the functional integrity of the dopaminergic system in psychiatric disorders.
Journal ArticleDOI

Cerebral metabolic effects of intravenous glycine in healthy human subjects.

TL;DR: It is suggested that studies of whole-brain cerebral metabolism may be useful for studying glycine-related mechanisms in healthy humans because there is not a clear cognitive or behavioral signal related to glycine administration at doses thought to be important clinically in patient populations.
Journal ArticleDOI

Drug characteristics derived from kinetic modeling: combined 11C-UCB-J human PET imaging with levetiracetam and brivaracetam occupancy of SV2A

TL;DR: In this paper , a nonlinear model was developed to estimate the brain entry rate of antiepileptic drugs, including levetiracetam (LEV) and brivaracetam(BRV), based on the displacement of SV2A tracer 11C-UCB-J.